Launch of the European Vaccines Hub (EVH) for Pandemic Readiness

We are pleased to announce a transformative step in public health as the Health Emergency Preparedness and Response Authority of the European Commission, through the European Health and Digital Executive Agency, supports the establishment of the European Vaccines Hub for Pandemic Readiness. This pan-European center, dedicated to advancing public-health–relevant vaccine development, has received co-funding for 4- years from the European Union’s EU4Health programme.

By integrating excellence in vaccine research, human monoclonal antibody (H-mAbs) development, clinical trials, and scalable manufacturing activities, the EVH will create a dynamic and collaborative environment. The EVH consortium brings together 11 Beneficiaries and 13 Affiliated and Associated entities from 7 European countries.

The project is structured around four pillars:

• Discovery - Led by Fondazione Biotecnopolo di Siena (Italy)
• Preclinical Studies - Led by Institut Pasteur (France)
• Clinical Studies - Led by Vaccinopolis (UAntwerpen, Belgium)
• Manufacturing - Led by DZIF and ZEPAI (Germany)

This initiative focuses on developing pandemic-prototype vaccines and scalable technologies, ensuring effective coordination of national vaccine research programs.

| Download  |